| 2023-07 | Discovery of 3-((3-amino-1H-indazol-4-yl)ethynyl)-N-(4-((4-ethylpiperazin-1-yl)methyl)-3-(trifluoromethyl)phenyl)benzamide (AKE-72), a potent Pan-BCR-ABLinhibitor including the T315I gatekeeper resistant mutant | Ashraf kareem; Kim Hyun Ji; Jung Woo Park; Yunju Nam; Hur, Wooyoung; Bang, Eun Kyoung; KEUM, GYO CHANG |
| 2023-02 | Discovery of New Quinolone-Based Diarylamides as Potent B-RAFV600E/C-RAF Kinase Inhibitors Endowed with Promising In Vitro Anticancer Activity | Kim Hyun Ji; Park, Jung Woo; Seo, Sangjae; Cho, Kwang-Hwi; Alanazi, Mohammed M.; Bang, Eun Kyoung; Keum, Gyochang; Ashraf kareem |
| 2023-01 | Identification of New N-methyl-piperazine Chalcones as Dual MAO-B/AChE Inhibitors | Ashraf kareem; Park, Jong Eun; Kim Hyun Ji; Lee, Jinhyuk; Bang, Eun-Kyoung; Kim, Hoon; Keum, Gyochang |
| 2024-04 | Identification of Ureidocoumarin-Based Selective Discoidin Domain Receptor 1 (DDR1) Inhibitors via Drug Repurposing Approach, Biological Evaluation, and In Silico Studies | Ashraf kareem; Kim Hyun Ji; Ahmed A. Al-Karmalawy; Radwan Alnajjar; Mohamed M. Khalifa; Bang, Eun-Kyoung; KEUM, GYO CHANG |
| 2023-03 | Overcoming the clinically resistant BCR-ABL mutants with new ureidobenzothiazole chemotypes endowed with potent and broad-spectrum anticancer activity | Ashraf kareem; Jin Heewon; Jung Woo Park; Kim Hyun Ji; Hanan Khojah; SEO, SEON HEE; Lee Ju hyeon; Bang, Eun-Kyoung; KEUM, GYO CHANG |
